Crocs Valuation
Is CROX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CROX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CROX * (MX$2384.18) is trading below our estimate of fair value (MX$3793.26)
Significantly Below Fair Value: CROX * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CROX *?
Other financial metrics that can be useful for relative valuation.
What is CROX *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$8.82b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.7x |
Enterprise Value/EBITDA | 9.6x |
PEG Ratio | 2x |
Price to Earnings Ratio vs Peers
How does CROX *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 52.7x | ||
7936 ASICS | 33.2x | 8.6% | JP¥1.5t |
PUM PUMA | 28.3x | 17.8% | €7.8b |
SKX Skechers U.S.A | 17.8x | 12.6% | US$10.4b |
ONON On Holding | 131.8x | 28.8% | US$9.8b |
CROX * Crocs | 11.1x | 5.6% | Mex$8.8b |
Price-To-Earnings vs Peers: CROX * is good value based on its Price-To-Earnings Ratio (11.1x) compared to the peer average (52.7x).
Price to Earnings Ratio vs Industry
How does CROX *'s PE Ratio compare vs other companies in the Global Luxury Industry?
Price-To-Earnings vs Industry: CROX * is good value based on its Price-To-Earnings Ratio (11.1x) compared to the Global Luxury industry average (19.4x).
Price to Earnings Ratio vs Fair Ratio
What is CROX *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 11.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CROX *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,384.18 | Mex$2,638.10 +10.7% | 10.4% | Mex$3,194.30 | Mex$2,084.70 | n/a | 12 |
May ’25 | n/a | Mex$2,481.78 0% | 10.0% | Mex$2,842.34 | Mex$2,110.48 | n/a | 13 |
Apr ’25 | n/a | Mex$2,344.60 0% | 13.4% | Mex$2,777.46 | Mex$1,579.99 | n/a | 15 |
Mar ’25 | n/a | Mex$2,342.62 0% | 12.1% | Mex$2,735.06 | Mex$1,623.94 | n/a | 14 |
Feb ’25 | n/a | Mex$2,135.81 0% | 18.3% | Mex$2,733.84 | Mex$1,349.83 | n/a | 12 |
Jan ’25 | n/a | Mex$2,098.51 0% | 19.9% | Mex$2,748.38 | Mex$1,357.01 | n/a | 12 |
Dec ’24 | n/a | Mex$2,083.63 0% | 21.0% | Mex$2,778.18 | Mex$1,371.72 | n/a | 11 |
Nov ’24 | Mex$1,599.59 | Mex$2,388.82 +49.3% | 21.4% | Mex$3,373.53 | Mex$1,841.77 | n/a | 11 |
Oct ’24 | n/a | Mex$2,301.42 0% | 20.5% | Mex$3,172.60 | Mex$1,732.07 | n/a | 10 |
Sep ’24 | Mex$1,591.40 | Mex$2,357.31 +48.1% | 18.0% | Mex$3,171.66 | Mex$1,748.70 | n/a | 10 |
Aug ’24 | Mex$1,800.00 | Mex$2,355.94 +30.9% | 16.7% | Mex$3,097.71 | Mex$1,707.93 | n/a | 10 |
Jul ’24 | Mex$1,941.00 | Mex$2,736.74 +41.0% | 12.5% | Mex$3,274.89 | Mex$2,195.06 | n/a | 10 |
Jun ’24 | Mex$1,840.00 | Mex$2,736.74 +48.7% | 12.5% | Mex$3,274.89 | Mex$2,195.06 | n/a | 10 |
May ’24 | Mex$2,230.00 | Mex$3,001.01 +34.6% | 25.8% | Mex$5,214.17 | Mex$2,229.51 | n/a | 11 |
Apr ’24 | n/a | Mex$2,973.77 0% | 26.8% | Mex$5,246.85 | Mex$2,134.93 | n/a | 11 |
Mar ’24 | Mex$2,246.00 | Mex$3,017.45 +34.3% | 28.4% | Mex$5,326.00 | Mex$2,167.13 | n/a | 10 |
Feb ’24 | n/a | Mex$2,511.66 0% | 14.5% | Mex$3,095.28 | Mex$1,932.21 | n/a | 9 |
Jan ’24 | Mex$2,000.00 | Mex$1,946.74 -2.7% | 15.6% | Mex$2,336.09 | Mex$1,465.01 | n/a | 9 |
Dec ’23 | n/a | Mex$1,795.57 0% | 16.0% | Mex$2,244.47 | Mex$1,268.61 | n/a | 9 |
Nov ’23 | n/a | Mex$1,734.85 0% | 18.5% | Mex$2,302.01 | Mex$1,080.95 | Mex$1,599.59 | 9 |
Oct ’23 | Mex$1,433.00 | Mex$1,720.28 +20.0% | 19.2% | Mex$2,300.38 | Mex$1,080.18 | n/a | 9 |
Sep ’23 | n/a | Mex$1,753.66 0% | 20.0% | Mex$2,321.39 | Mex$1,090.04 | Mex$1,591.40 | 8 |
Aug ’23 | Mex$1,487.80 | Mex$1,830.32 +23.0% | 25.6% | Mex$2,557.90 | Mex$1,105.01 | Mex$1,800.00 | 9 |
Jul ’23 | n/a | Mex$2,017.39 0% | 26.0% | Mex$2,608.35 | Mex$1,202.28 | Mex$1,941.00 | 8 |
Jun ’23 | Mex$1,128.00 | Mex$2,017.39 +78.8% | 26.0% | Mex$2,608.35 | Mex$1,202.28 | Mex$1,840.00 | 8 |
May ’23 | n/a | Mex$2,924.43 0% | 40.0% | Mex$5,026.44 | Mex$1,634.62 | Mex$2,230.00 | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.